CVMP opinions on veterinary medicinal products

The Committee adopted by consensus a positive opinion for a grouping of variations requiring assessment for Metacam (meloxicam), from Boehringer Ingelheim Vetmedica GmbH, to modify the indication for use in cats for Metacam 5 mg/ml solution for injection for dogs and cats and to amend the product information for Metacam 5 mg/ml solution for injection for dogs and cats, Metacam 2 mg/ml solution for injection for cats, and Metacam 0.5 mg/ml oral suspension for cats and guinea pigs with regard to the follow-up oral treatment after initial injectable administration in cats.

The Committee adopted by consensus positive opinions for variations requiring assessment concerning quality-related changes for:

• Fevaxyn Pentofel/Suvaxyn CSF Marker/Suvaxyn PRRS MLV (subject to worksharing)
• Rexxolide

Union referrals and related procedures

The Committee concluded the follow-up assessment procedure of the conditions on the marketing authorisations for…